- 1、本文档共5页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
UPS 2011 PAIN IN THE (SUPPLY) CHAIN SURVEY
Taking the Pulse of Global Change
Healthcare manufacturers around the globe are gearing up for rapid change,
according to the fourth annual UPS “Pain in the (Supply) Chain” survey
conducted by TNS. The survey explores top business and supply chain
concerns of senior-level decision makers at nearly 250 pharmaceutical,
biotech and medical device companies in the U.S., Europe and Asia. It also
uncovers global trends impacting healthcare supply chains.
Findings from 2011 show that companies are focused on three areas:
Investment (in technology and global expansion); Protection (in areas of
intellectual property and product security) and Acceleration (in levels of
concern around issues and changes in the supply chain). /healthcare
2011 KEY FINDINGS
Findings are organized around the following trend areas:
Global issues and concerns: Growth strategies: Other trends:
• Reform, regulations and legislation • Global market expansion • Changing channel strategies
• Intellectual property protection • Technology investment • Sustainability drivers
• Cost management
TOP HEALTHCARE BUSINESS CONCERNS BY MARKET
Changes in healthcare legislation and reform top the list of business concerns of healthcare companies in the U.S. and
Asia – cited by 60% and 53% of companies respectively – while increasing regulations ranks highest in concern among
European decision makers (49%).
US EUROPE ASIA
Reform/Legislation: 60% Reform/Legislation: 43% Reform/Legislation: 53%
Regulations: 43% Regulations: 49% Regulations: 49%
Competition: 30%
文档评论(0)